Comparative Study of Hypo-Fractionated Radiotherapy Versus Conventional Radiotherapy in Breast Cancer

被引:0
|
作者
Narwariya, Abhinav [1 ]
Dhakar, Mhendr [2 ]
Jatav, Jagannath [3 ]
Prajapati, Raju [4 ]
Bayer, Sujata [5 ]
Moosa, Shajiya Sarwar [5 ]
Shaikh, Mohammad Habeebur Raheman [5 ]
Ali, Mohammed Taher [6 ]
Ahmad, Arafat [7 ]
Begum, Yousuf [5 ]
Hiware, Sanket D. [5 ]
机构
[1] Apollo Hosp, Med Oncol, New Delhi, India
[2] All India Inst Med Sci, Radiat Oncol, Raipur, India
[3] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Pathol, Rewa, India
[4] Shyam Shah Med Coll & Sanjay Gandhi Mem Hosp, Radiat Oncol, Rewa, India
[5] Imam Abdulrahman Bin Faisal Univ, Anat, Dammam, Saudi Arabia
[6] Imam Abdulrahman Bin Faisal Univ, Clin Pharmacol, Dammam, Saudi Arabia
[7] Imam Abdulrahman Bin Faisal Univ, Biochem, Dammam, Saudi Arabia
关键词
breast cancer radiotherapy; hypofractionation; lumpectomy; mastectomy; conventional radiotherapy; RADIATION-THERAPY; WOMEN; RISK;
D O I
10.7759/cureus.29147
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Breast cancer is the most commonly diagnosed cancer causing death among females worldwide. Radiotherapy after lumpectomy/mastectomy in breast cancer cases is a successful treatment modality taking five weeks to complete. The aim of the present study is to compare the effectiveness of hypo-fractionated radiotherapy in breast cancer patients with conventional radiotherapy with respect to outcome and toxicity.Methods: Sixty patients were randomly divided equally into a conventional group, Group A (dose: 50 Gy in 25 fractions), and a hypo-fractionated short-course radiotherapy group, Group B (dose: 40 Gy in 16 fractions). After thorough clinical and laboratory examination of all patients, the disease status was assessed prior to radiotherapy and three and six months after completion of radiotherapy. The cardiopulmonary function was assessed using echocardiography and pulmonary function tests prior to the procedure. The assessment of the development of toxicity (dysphagia, skin, lung, and lymphedema) was done during every clinical visit.Results: The mean age of patients was 53.28 +/- 9.73 years in Group A, and 55.67 +/- 10.41 years in Group B (p=0.82). The right breast was involved in 13 (43.4%) patients in Group A and 14 (46.6%) in Group B, and the left breast was involved n 17 (56.6%) patients in Group A and 16 (53.4%) in Group B (p=0.81). Most of the patients were post-menopausal; 24 (80%) in Group A and 25 (83.4%) in Group B (p=0.91). Eleven (36.6%) patients were of stage T2N1M0 in both groups. However, no statistical difference was observed between the groups in the TNM (tumor, node, and metastasis) staging using the AJCC (American Joint Committee on Cancer) criteria (p=0.26). On comparing the responses in Group A and Group B, no significant difference was observed in either of the groups from immediate post-treatment to the 12-month follow-up period (p=0.53 and p=0.64, respectively).Conclusion: Hypo-fractionated radiotherapy is as effective as conventional radiotherapy and can be used as an alternative method for treatment following breast cancer surgery.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] COMPARISON OF RADIATION-INDUCED TOXICITIES, TREATMENT FEASIBILITY IN CONVENTIONAL VERSUS HYPO-FRACTIONATED PROTOCOLS OF POST MASTECTOMY RADIOTHERAPY
    Kumar, Sanjal, V
    Baskar, P.
    Sunderesan, C.
    Kumar, Harish P. R.
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (06): : 767 - 770
  • [22] A prospective phase I study of hypo-fractionated neoadjuvant radiotherapy for locally advanced gastric cancer
    Ning Li
    Xin Wang
    Yuan Tang
    Dongbing Zhao
    Yihebali Chi
    Lin Yang
    Liming Jiang
    Jun Jiang
    Wenyang Liu
    Yu Tang
    Hui Fang
    Yueping Liu
    Yongwen Song
    Shulian Wang
    Jing Jin
    Yexiong Li
    BMC Cancer, 18
  • [23] Neuro-ophthalmologic outcomes of standard versus hypo-fractionated stereotactic radiotherapy of AVPM
    Zach, Leor
    Agami, Amir
    Furman, Orit
    Attia, Moshe
    Cohen, Zvi
    Mizrachi, Iris Ben-Bassat
    Tam, Guy
    Zibly, Zion
    Nissim, Ouzi
    Spiegelmann, Roberto
    Huna-Baron, Ruth
    RADIATION ONCOLOGY, 2021, 16 (01)
  • [24] Moderately hypo-fractionated radiotherapy with concurrent chemotherapy for cervical carcinoma
    Singh, Shreya
    Shah, Manav
    Shahi, Uday Pratap
    Jaiswal, Isha
    Mishra, Himanshu
    Mishra, Ritusha
    Prakash, Chandra
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1098 - S1100
  • [25] Successful Conformal Avoidance for Extremely Hypo-Fractionated Prostate Radiotherapy
    Stroom, J.
    Greco, C.
    Pares, O.
    Pimentel, N.
    Louro, V.
    Vieira, S.
    Kociolek, J.
    Fuks, Z.
    MEDICAL PHYSICS, 2020, 47 (06) : E387 - E387
  • [26] VOLUME CHANGES WITH HYPO-FRACTIONATED RADIOTHERAPY IN EARLY LUNG CANCER: TIME TRENDS & OUTCOMES
    Pathak, R. S.
    Tibdewal, A. R.
    Laskar, S. Ghosh
    Chaudhari, S.
    Agarwal, J. P.
    ANNALS OF ONCOLOGY, 2015, 26
  • [27] Acute effects after HYPO-fractionated radiotherapy (HYPORT) of intermediate risk prostate cancer
    Widmark, A
    Fransson, P
    Bergström, P
    Löfroth, P
    Zackrisson, B
    Franzen, L
    RADIOTHERAPY AND ONCOLOGY, 2004, 73 : S408 - S408
  • [28] Early outcome of first Vietnamese series of moderately hypo-fractionated prostate cancer radiotherapy
    Mbarek, Basma
    Thu Nguyen Huynh Ha
    Duong Tran Anh
    Tin Phang Duc Tin
    Thao Vo
    RADIOTHERAPY AND ONCOLOGY, 2024, 197 : S288 - S289
  • [29] Treatment Verification of Hypo-Fractionated Lung Radiotherapy Using Cine EPID
    Mackenzie, A.
    Jiang, S.
    MEDICAL PHYSICS, 2008, 35 (06) : 2723 - +
  • [30] Variability in free-breathing of patients undergoing hypo-fractionated radiotherapy for liver cancer
    Moseley, D. J.
    Jaffray, D. A.
    Dawson, L. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S53 - S53